Introducing ADVATE 3000 IU. Save time with fewer vials and less infusion volume.* Is 3000 IU right for you? (* As compared to RECOMBINATE.)
Learn more about ADVATE 3000 IUBAXJECT II Needle-less Transfer Device. Mixing as easy as 1-2-3.
Download instructions [PDF]Indications:
ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method] is indicated in hemophilia A (classical hemophilia) for the prevention and control of bleeding episodes and for perioperative management of patients with hemophilia A.
ADVATE is not indicated for the treatment of von Willebrand’s disease.
Important Safety Information:
Let your doctor know if you have had any previous allergic reactions to other factor VIII products or mouse or hamster proteins.
The most common related adverse reactions observed during the ADVATE clinical studies include: strange taste in mouth, headache, dizziness, and redness in the face.
There is a possibility that you can have an allergic reaction to ADVATE. Symptoms of an allergic reaction may include rash, hives, itching, tightness in throat or chest, difficulty breathing, feeling dizzy or light-headed, or a weak pulse. If you experience any of these symptoms, stop the infusion immediately and promptly contact your doctor.
Contact your doctor if you are not able to prevent or control bleeding episodes with your regular doses of factor VIII therapy.
Reference:
1. Industry, financial, and research reports on file. Westlake Village, CA: Baxter Healthcare Corporation; July 2007.
